We are an intentionally small, focused consultancy working on concept development and refinement for combination products (medicine in a delivery device). Combination products are being used to treat autoimmune diseases, cancer, Alzheimer’s, Parkinson’s, asthma, eye diseases, diabetes, stroke, and cardiovascular disease. “Smart” delivery devices and connected systems are a significant part of our work.
Small but mighty, we dominate the early concept phase of this work. Our team of engineers, clinicians, and businesspeople start from client molecule pipelines and strategies.
Insatiably curious researchers, we understand the nuances of patients, caregivers, and HCPs. Not content to just report findings, we are inventors, compelled to invent useful and usable product and service concepts that differentiate. Because devices can only help if patients receive them, we use our corporate experience to build compelling, data-driven business cases that illustrate the possibilities, inspiring confidence for investment decisions. Many companies may do one part of this, but we’re unique in bringing these perspectives together around specialty pharmaceuticals.
Our approach is unconventional, the quality of our results turns heads, and we’ve built a company through word of mouth alone. Clients give us projects that defy simple requests for proposals and easy elevator speeches.
Our team is intentionally small and recognized by our pharma clients as being the best at what we do. We’ve been described by clients as “mercenaries for value creation” and “the SEAL team of concept development.” We’ve set aside jargon, departments, hierarchy, and cookie-cutter approaches, instead favoring nimbleness, cleverness, and raw intellectual horsepower and bandwidth. Laser focus on team and craft lets us continue delivering work that is the envy of the industry at mind-bending speed.